IMA
ImageneBio Inc
There isn't enough reported data to score IMA yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
IMA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IMA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IMA PE Valuation
IMA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
IMA Forward outlook
There aren't enough analyst estimates for IMA to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IMA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$8.19 | +$6.45 |
| Q2 2025 | -$7.80 | +$9.12 |
| Q1 2025 | -$10.44 | +$8.40 |
| Q4 2024 | -$12.24 | +$7.32 |
| Q3 2024 | -$14.64 | +$4.68 |
| Q2 2024 | -$16.92 | +$3.36 |
| Q1 2024 | -$18.84 | +$3.00 |
| Q4 2023 | -$19.56 | +$3.24 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 156% for IMA versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
IMA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $659K | -88% |
| Q3 2023 | $1.2M | -81% |
| Q2 2023 | $2M | +425% |
| Q1 2023 | $5.3M | +57% |
| Q4 2022 | $5.5M | -73% |
| Q3 2022 | $6.4M | +71% |
| Q2 2022 | $382K | -89% |
| Q1 2022 | $3.4M | -2.6% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for IMA versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2023 | -3324% | -3047 points |
| Q3 2023 | -1646% | -1367 points |
| Q2 2023 | -923% | +4562 points |
| Q1 2023 | -292% | +209 points |
| Q4 2022 | -277% | -291 points |
| Q3 2022 | -279% | +108 points |
| Q2 2022 | -5485% | -5127 points |
| Q1 2022 | -501% | -221 points |
IMA's operating margin was −3324% last quarter, down 3047 points from the same quarter a year ago, near the bottom of its range since 2021.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
IMA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$9.5M | +$17.1M |
| Q2 2026 | -$9.1M | -$5.7M |
| Q1 2026 | -$14.8M | -$4.2M |
| Q4 2023 | -$22.1M | -$4.2M |
| Q3 2023 | -$20M | -$1.6M |
| Q2 2023 | -$18.1M | +$1.3M |
| Q1 2023 | -$19.9M | -$119K |
| Q4 2022 | -$17.9M | -$4M |
IMA has burned cash in almost every quarter: −$41M over the past year, against −$63M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over IMA on cash generation, producing positive trailing cash flow while its opponent burns cash.
IMA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.9% | +961K shares |
| 1 year | +326% | +13.1M shares |
| 3 years | +423% | +13.8M shares |
IMA has 17M diluted shares, up 326% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over IMA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
IMA Net Leverage
IMA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
IMA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 6.5 | Oversold |
IMA's weekly RSI is 26 (oversold) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
IMA PE vs Healthcare Sector
| Metric | IMA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
IMA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
IMA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.18 | 17% below |
| 20 week MA | $4.95 | 30% below |
| 50 week MA | $5.63 | 39% below |
| 100 week MA | $9.77 | 65% below |
| 200 week MA | $23.0 | 85% below |
IMA is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over IMA on trend strength, trading above more of its moving averages.
IMA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $384.0 | $178.1 | -54% |
| 2022 | $178.1 | $34.2 | -81% |
| 2023 | $34.2 | $23.6 | -31% |
| 2024 | $23.6 | $18.5 | -22% |
| 2025 | $18.5 | $5.80 | -69% |
| 2026 YTD | $5.80 | $3.45 | -41% |
IMA has finished every year since 2021 lower, and it's down 41% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over IMA on returns for 2026, with the stronger performance.